Summary
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
Market Segment as follows:
By Type
Tofacitinib
Ruxolitinib
Baricitinib
By Application
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
By Company
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Tofacitinib
1.1.2.2 Ruxolitinib
1.1.2.3 Baricitinib
1.1.3 Market by Application
1.1.3.1 Rheumatoid Arthritis (RA)
1.1.3.2 Polycythemia Vera (PCV)
1.1.3.3 Myelofibrosis (MF)
1.1.3.4 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Pfizer
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Incyte
6.3 Novartis
6.4 Eli Lilly
6.5 Gilead
6.6 Sanofi
6.7 Galapagos
6.8 AbbVie
6.9 Vertex
6.10 Teva
6.11 Astellas Pharma
6.12 Celgene
6.13 CTI BioPharma
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Tofacitinib Market Size and CAGR 2013-2018 (Million USD)
Figure Tofacitinib Market Size and CAGR 2013-2018 (Volume)
Figure Tofacitinib Market Forecast and CAGR 2019-2025 (Million USD)
Figure Tofacitinib Market Forecast and CAGR 2019-2025 (Volume)
Figure Ruxolitinib Market Size and CAGR 2013-2018 (Million USD)
Figure Ruxolitinib Market Size and CAGR 2013-2018 (Volume)
Figure Ruxolitinib Market Forecast and CAGR 2019-2025 (Million USD)
Figure Ruxolitinib Market Forecast and CAGR 2019-2025 (Volume)
Figure Baricitinib Market Size and CAGR 2013-2018 (Million USD)
Figure Baricitinib Market Size and CAGR 2013-2018 (Volume)
Figure Baricitinib Market Forecast and CAGR 2019-2025 (Million USD)
Figure Baricitinib Market Forecast and CAGR 2019-2025 (Volume)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2018 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Size and CAGR 2013-2018 (Volume)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Rheumatoid Arthritis (RA) Market Forecast and CAGR 2019-2025 (Volume)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2018 (Million USD)
Figure Polycythemia Vera (PCV) Market Size and CAGR 2013-2018 (Volume)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Polycythemia Vera (PCV) Market Forecast and CAGR 2019-2025 (Volume)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2018 (Million USD)
Figure Myelofibrosis (MF) Market Size and CAGR 2013-2018 (Volume)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2019-2025 (Million USD)
Figure Myelofibrosis (MF) Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure China Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Million USD)
Figure China Tyrosine Kinase JAK Inhibitors Market Size and CAGR 2013-2017 (Volume)
Figure China Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Tyrosine Kinase JAK Inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Tyrosine Kinase JAK Inhibitors SWOT List
Figure Tyrosine Kinase JAK Inhibitors Porter's Five Forces
